Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
56
BLKB Quote, Financials, Valuation and Earnings
Last price:
$63.98
Seasonality move
:
3.06%
Day range:
$62.75 - $64.23
52-week range:
$58.05 - $88.95
Dividend yield:
0%
P/E ratio:
69.57x
P/S ratio:
2.79x
P/B ratio:
92.93x
Volume:
218.1K
Avg. volume:
280.2K
1-year change:
-18.22%
Market cap:
$3.1B
Revenue:
$1.2B
EPS (TTM):
-$5.82
Analysts' Opinion
-
Consensus RatingBlackbaud has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $71.33, Blackbaud has an estimated upside of 12.27% from its current price of $63.54.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $60.00 representing 100% downside risk from its current price of $63.54.
Fair Value
-
According to the consensus of 3 analysts, Blackbaud has 12.27% upside to fair value with a price target of $71.33 per share.
BLKB vs. S&P 500
-
Over the past 5 trading days, Blackbaud has underperformed the S&P 500 by -4.02% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Blackbaud does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Blackbaud revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Blackbaud reported revenues of $270.7M.
Earnings Growth
-
Blackbaud has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Blackbaud reported earnings per share of $0.10.
Enterprise value:
4.3B
EV / Invested capital:
--
Price / LTM sales:
2.79x
EV / EBIT:
32.37x
EV / Revenue:
3.71x
PEG ratio (5yr expected):
--
EV / Free cash flow:
25.73x
Price / Operating cash flow:
19.40x
Enterprise value / EBITDA:
17.52x
Gross Profit (TTM):
$642M
Return On Assets:
-11.08%
Net Income Margin (TTM):
-24.72%
Return On Equity:
-77.44%
Return On Invested Capital:
-19.76%
Operating Margin:
7.55%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1.1B | $1.1B | $279.3M | $270.7M | |
| Gross Profit | $557.6M | $617.6M | $642M | $153M | $155.8M | |
| Operating Income | -$32.5M | $65.4M | $144.6M | $10.7M | $20.4M | |
| EBITDA | $81.2M | $191.9M | -$134.3M | $44.2M | $44.2M | |
| Diluted EPS | -$0.96 | $0.41 | -$5.82 | $0.10 | $0.10 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $465.3M | $507.1M | $579.3M | $577.1M | $627.5M | |
| Total Assets | $1.7B | $2.6B | $2.6B | $2.5B | $2.1B | |
| Current Liabilities | $646.1M | $758.9M | $863.9M | $862.6M | $863.9M | |
| Total Liabilities | $1.3B | $1.9B | $1.9B | $2B | $2.1B | |
| Total Equity | $416.2M | $705.1M | $719.7M | $534.1M | $33.2M | |
| Total Debt | $550.8M | $981.2M | $878M | $1B | $1.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $201.2M | $242.4M | $232.7M | $64.6M | $1.4M | |
| Cash From Investing | -$63.9M | -$63.6M | -$84.8M | -$14.5M | -$25.9M | |
| Cash From Financing | -$53.5M | -$184.4M | -$74.7M | -$394.6M | -$330M | |
| Free Cash Flow | $131.8M | $180.3M | $165.2M | $51.3M | -$12.3M | |
BLKB
Sector
Market Cap
$3.1B
$83.5M
Price % of 52-Week High
71.43%
64.2%
Dividend Yield
0%
0%
Shareholder Yield
5.66%
0.68%
1-Year Price Total Return
-18.22%
-12.88%
Beta (5-Year)
1.141
0.814
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$64.60
200-day SMA
Sell
Level
$71.87
Bollinger Bands (100)
Buy
Level
61.52 - 65.14
Chaikin Money Flow
Buy
Level
75.6M
20-day SMA
Sell
Level
$64.05
Relative Strength Index (RSI14)
Sell
Level
48.45
ADX Line
Sell
Level
17.95
Williams %R
Neutral
Level
-72.1174
50-day SMA
Buy
Level
$63.29
MACD (12, 26)
Buy
Level
0.29
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
54.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.8726)
Sell
CA Score
(Annual)
Level (-2.213)
Buy
Beneish M-Score
(Annual)
Level (-3.8654)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (3.0896)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Founded in 1981, Blackbaud provides software solutions designed to serve the “social good” community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
Stock Forecast FAQ
In the current month, BLKB has received 0 Buy ratings 3 Hold ratings, and 0 Sell ratings. The BLKB average analyst price target in the past 3 months is $71.33.
-
Where Will Blackbaud Stock Be In 1 Year?
According to analysts, the consensus estimate is that Blackbaud share price will rise to $71.33 per share over the next 12 months.
-
What Do Analysts Say About Blackbaud?
Analysts are divided on their view about Blackbaud share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Blackbaud is a Sell and believe this share price will drop from its current level to $60.00.
-
What Is Blackbaud's Price Target?
The price target for Blackbaud over the next 1-year time period is forecast to be $71.33 according to 3 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is BLKB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Blackbaud is a Hold. 3 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BLKB?
You can purchase shares of Blackbaud via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Blackbaud shares.
-
What Is The Blackbaud Share Price Today?
Blackbaud was last trading at $63.98 per share. This represents the most recent stock quote for Blackbaud. Yesterday, Blackbaud closed at $63.54 per share.
-
How To Buy Blackbaud Stock Online?
In order to purchase Blackbaud stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
